Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study) - Ohta, S; Tsuru, T; Terao, K (J Clin Pharmacol, 2014)
et al.